Document Detail

Survival after intrauterine myocardial infarction: noninvasive assessment of myocardial perfusion with 99mTc-Sestamibi scintigraphy.
MedLine Citation:
PMID:  11144313     Owner:  NLM     Status:  MEDLINE    
Survival after severe intrauterine myocardial infarction has not been reported previously. We describe the course of a neonate with a structurally normal heart, who presented with cardiogenic shock at birth due to intrauterine myocardial infarction with a huge ventricular aneurysm. Myocardial perfusion was assessed noninvasively by means of 99mTc-Sestamibi, a radiopharmaceutical agent recently introduced in nuclear cardiology to avoid repeated coronary angiography. The patient survived with improved cardiac function and normal neurodevelopmental outcome.
R Birnbacher; U Salzer-Muhar; A Kurtaran; M Marx; S Kuhle; A Pollak
Related Documents :
1894853 - Limitations of thrombolytic therapy for acute myocardial infarction complicated by cong...
21523383 - The paradox of low bnp levels in obesity.
16669843 - The implications of a growing evidence base for drug use in elderly patients. part 3. b...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  American journal of perinatology     Volume:  17     ISSN:  0735-1631     ISO Abbreviation:  Am J Perinatol     Publication Date:  2000  
Date Detail:
Created Date:  2000-12-28     Completed Date:  2001-03-01     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8405212     Medline TA:  Am J Perinatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  309-13     Citation Subset:  IM    
Department of Neonatology and Intensive Care, University Children's Hospital Vienna, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Disease-Free Survival
Fetal Diseases / physiopathology,  radionuclide imaging*
Follow-Up Studies
Gestational Age
Myocardial Infarction / physiopathology,  radionuclide imaging*
Pregnancy Outcome*
Prenatal Diagnosis / methods*
Sensitivity and Specificity
Technetium Tc 99m Sestamibi / diagnostic use*
Reg. No./Substance:
109581-73-9/Technetium Tc 99m Sestamibi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Outcome of 306 twin deliveries according to first twin presentation and method of delivery.
Next Document:  Gram-stain diagnosis of bacterial vaginosis after rupture of membranes.